ACSL4 and hepatocellular carcinoma: Immunohistochemical staining of ACSL4 was less effective at distinguishing HCC from hepatic metastases (AUC 0.801; CI (0.736– 0.867); sensitivity 62.4 %; specificity 94.3 % (Table 3)).